ImmunityBio, Inc. - Common Stock (NQ:IBRX)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
17.3% below 52-week high
10.29
1.9552W Low
12.4352W High
1 Week
2.5% below 1-week high
8.261W Low
10.551W High
ImmunityBio, Inc. - Common Stock (IBRX) traded between $1.95 and $12.43 over the past 52 weeks and last traded at $10.29, 17.3% below its 52-week high. Over the past week it ranged between $8.26 and $10.55.
Past 12 Months
1W
+$1.85
1M
+$2.42
3M
+$0.85
6M
+$2.99
YTD
+$8.27
1Y
+$7.80
IBRX was +314.7% over the past year, +40.9% over six months, +409.2% year to date, +21.9% in the last week.
12 Months vs Market
IBRX
DIA
SPY
QQQ
IWM
Over the past 12 months IBRX returned +314.7% versus DIA (Dow) +10.1%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +16.1%.
Volume & Liquidity
3.08× 3-mo avg
Today 31,292,563
3-mo avg 10.2M
1W
1M
3M
6M
YTD
1Y
IBRX most recently traded 31,292,563 shares against a 3-month average daily volume of 10.2M. More NewsRead MoreFrequently Asked QuestionsIs ImmunityBio, Inc. - Common Stock publicly traded?
Yes, ImmunityBio, Inc. - Common Stock is publicly traded.
What exchange does ImmunityBio, Inc. - Common Stock trade on?
ImmunityBio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImmunityBio, Inc. - Common Stock?
The ticker symbol for ImmunityBio, Inc. - Common Stock is IBRX on the Nasdaq Stock Market
What is the current price of ImmunityBio, Inc. - Common Stock?
The current price of ImmunityBio, Inc. - Common Stock is 10.29
When was ImmunityBio, Inc. - Common Stock last traded?
The last trade of ImmunityBio, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of ImmunityBio, Inc. - Common Stock?
The market capitalization of ImmunityBio, Inc. - Common Stock is 4.02B
How many shares of ImmunityBio, Inc. - Common Stock are outstanding?
ImmunityBio, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
